Preface

Drug discovery has traditionally demanded immense time, resources, and financial investment. Computer-Aided Drug Design (CADD) has revolutionized this process by integrating computational chemistry, molecular modeling, and bioinformatics with experimental pharmacology. These approaches enable efficient identification, optimization, and validation of potential drug candidates while significantly reducing costs and timelines. By simulating molecular interactions, predicting pharmacokinetic properties, and guiding lead optimization, CADD enhances precision and success rates in drug development. Today, it is not merely a supportive tool but a central component of pharmaceutical research, accelerating innovation and enabling the design of safer, more effective, and targeted therapeutic agents.

The motivation behind this book, “Computer-Aided Drug Design: Principles, Techniques, and Applications,” lies in providing a comprehensive understanding of both the fundamental principles and the cutting-edge applications of CADD. This volume aims to highlight how advancements in algorithms, computational power, and molecular databases have enabled researchers to probe drug-receptor interactions, predict molecular properties, and design safer, more effective therapeutics. The book is systematically structured to ensure that readers can navigate from foundational knowledge to specialized applications. The opening chapters introduce the history and evolution of CADD, tracing its development from elementary molecular modeling in the 1960s to present-day applications involving high-throughput virtual screening and artificial intelligence. The discussion provides an entry point into essential methods such as molecular docking, Quantitative Structure-Activity Relationship (QSAR) analysis, pharmacophore mapping, and ADMET prediction, supported by case studies and methodological insights.

A major focus of this volume is QSAR, a cornerstone of computational drug design. The chapters provide a detailed account of its origins, theoretical foundations, and evolution into modern 2D, 3D, and advanced 4D approaches. Key aspects such as descriptor selection, statistical modeling, and validation techniques are thoroughly discussed, with emphasis on ensuring predictive reliability. Applications across diverse biological systems illustrate QSAR’s wide utility in drug discovery. Beyond predictive modeling, QSAR is highlighted as an essential tool for mechanistic interpretation, guiding rational drug design and optimization of therapeutic candidates.

Another important section of the book delves into Molecular Mechanics (MM) and Quantum Mechanics (QM), highlighting how computational methods can capture interactions at the atomic level. Through approaches such as QM/MM hybrid techniques, energy minimization algorithms, and molecular dynamics simulations, the chapters illustrate how theoretical frameworks are applied to model complex biomolecular systems and ligand-receptor dynamics. These discussions are complemented by analyses of docking techniques, rigid, flexible, and hybrid methods, which are essential in evaluating binding affinities and guiding lead optimization. Real-world examples of docking against clinically relevant targets such as HIV protease and HMG-CoA reductase reinforce the practical impact of these methodologies.

The prediction and evaluation of ADMET properties are presented as a key stage in reducing attrition rates in drug discovery. This book emphasizes the integration of empirical rules such as Lipinski’s rule of five with modern computational platforms like SwissADME, pkCSM, and ADMETlab. The chapters demonstrate how early pharmacokinetic and toxicity predictions can enhance lead optimization and significantly improve the probability of clinical success. Closely linked to this discussion are chapters on de novo drug design and homology modeling, which present strategies for designing molecules from scratch and for predicting protein structures when experimental data are lacking.

Further depth is provided through dedicated chapters on pharmacophore mapping, virtual screening, and drug repurposing. These topics showcase how computational tools are applied not only to discover novel molecules but also to re-evaluate existing drugs for new therapeutic indications. The role of artificial intelligence and machine learning in transforming CADD is another highlight of the book. These chapters explore the integration of deep learning, reinforcement learning, and natural language processing in drug discovery workflows, demonstrating how generative models and advanced analytics are driving innovation in molecular design.

The concluding chapters of this volume extend the applications of CADD to advanced and specialized domains. Molecular Dynamics (MD) simulations are emphasized as powerful tools for understanding biomolecular flexibility, conformational dynamics, and thermodynamics that direct drug-target interactions. The book also explores computational strategies targeting epigenetic regulators, highlighting their potential to unlock innovative therapies for cancer, neurodegenerative, and other complex diseases. To enhance practical understanding, tutorials and software-based exercises are incorporated, providing readers with opportunities to apply theoretical knowledge directly in laboratory and academic settings, thereby fostering experiential learning.

This volume represents the collaborative efforts of researchers and academicians from varied domains, including pharmaceutical sciences, computational chemistry, and bioinformatics. Their combined expertise has shaped a text that effectively balances theoretical foundations with practical case studies, making it valuable for both academic and professional audiences. For students and research scholars, it provides a structured introduction to key concepts of CADD, while for researchers and practitioners, it offers comprehensive coverage of advanced methodologies, contemporary tools, and real-world applications in modern drug discovery and development.

In summary, this book seeks to provide readers with a holistic perspective on the discipline. By encompassing historical context, core methodologies, advanced computational strategies, and applied case studies, the book highlights the central role of CADD in modern drug discovery. It is our hope that this volume will serve not only as a reference text but also as an inspiration for future innovations in computational drug design, ultimately contributing to the development of safer, more targeted, and more effective therapeutics.